EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronic Stress and Astrocyte Dysfunction in Depression: Molecular Mechanisms and Gene Expression Changes

Natalia Bochenska iD, Julia Tomczak iD, Malwina Lisek

Antioxidants · 06.12.2025 · 14 (12) · 1464

DOI: 10.3390/antiox14121464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 06.12.2025. Verfasst von Natalia Bochenska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurochemistry, Medical University of Lodz, 92-215 Lodz, Poland. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a complex and heterogeneous psychiatric condition with high global prevalence and significant personal and societal burdens. While traditionally focused on neuronal dysfunction, emerging research highlights a critical role for astrocytes—glial cells essential for maintaining brain homeostasis in the pathogenesis of depression. This review explores how chronic stress, a major risk factor for MDD, disrupts astrocyte function through multiple converging mechanisms. We detail the normal physiological roles of astrocytes in synaptic regulation, neurotransmitter cycling, metabolic support, and neurovascular integrity, and examine how these functions are compromised under chronic stress. Key molecular pathways implicated include glucocorticoid receptor (GR) signaling dysregulation, neuroinflammatory responses, glutamate excitotoxicity, oxidative stress, and epigenetic alterations. Evidence from histological and transcriptomic studies in both human postmortem tissue and rodent models reveals consistent changes in astrocyte-specific genes, such as GFAP, SLC1A2, SLC1A3, BDNF, and AQP4, supporting their involvement in depressive pathology. Finally, we discuss therapeutic strategies targeting astrocyte dysfunction—including EAAT2 upregulation, neuromodulation, anti-inflammatory approaches, GR modulation, and glial-focused epigenetic therapies. Understanding astrocyte pathology in the context of chronic stress not only refines our understanding of MDD but also opens novel avenues for treatment development.

Schlagwörter

Stichwörter der Autor:innen

astrocyteschronic stressdepressionglial cellsmajor depressive disorder

Autor:innen und Institutionen

  • Department of Molecular Neurochemistry, Medical University of Lodz, 92-215 Lodz, Poland.

ORCID-Profile: Natalia Bochenska, Julia Tomczak

Förderung

  • National Science Center

Zitieren

APA

Bochenska, N., Tomczak, J., & Lisek, M. (2025). Chronic Stress and Astrocyte Dysfunction in Depression: Molecular Mechanisms and Gene Expression Changes. Antioxidants, 14(12), 1464. https://doi.org/10.3390/antiox14121464

Vancouver

Bochenska N, Tomczak J, Lisek M. Chronic Stress and Astrocyte Dysfunction in Depression: Molecular Mechanisms and Gene Expression Changes. Antioxidants. 2025;14(12):1464. doi:10.3390/antiox14121464

BibTeX
@article{Bochenska2025,
  author = {Bochenska, Natalia and Tomczak, Julia and Lisek, Malwina},
  title = {Chronic Stress and Astrocyte Dysfunction in Depression: Molecular Mechanisms and Gene Expression Changes},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {1464},
  doi = {10.3390/antiox14121464}
}
Kostenlos starten →